ClinicalTrials.gg
WithdrawnNCT05098431Updated Jul 12, 2024

Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery

An interventional study of Quadriceps and Rectus Femoris MEP Recording in Intervertebral Disc Degeneration, Intervertebral Disc Displacement and Spinal Stenosis, sponsored by Allina Health System. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-12.

Sponsored by Allina Health System · Not applicable, Interventional, and Diagnostic

Why this study was withdrawn
Unable to enroll patients.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Motor Evoked Potentials are an aspect of intraoperative neuromonitoring, a tool used by neurophysiologists during surgery to prevent irreversible damage to the spinal cord during procedures. This study investigates the utility of three separate quadriceps MEP recording approaches over a total of 40 limbs (20 participants).

Read the detailed description

The long-term objective of this research is to understand how differing recording techniques may enhance the ability to accurately identify clinically relevant changes in Motor Evoked Potentials (MEPs) during a variety of surgeries where the central motor tracts or lumbar spinal roots are at risk.The specific aims of the proposed research are:

  1. Using transcranial magnetic stimulation, evaluate the effects on compound muscle action potentials utilizing intramuscular bipolar recording vs subdermal referential recordings vs subdermal bipolar recordings.
  2. Evaluated the variability of amplitude and area between the intramuscular and subdermal recording techniques.

The initial focus will be on recording techniques to obtain stable MEPs in a proximal lower limb muscle, specifically the quadriceps. Continuation research may focus on stimulation techniques to facilitate proximal MEPs and ultimately to improved specificity of MEP changes.

02

Conditions studied

  • Intervertebral Disc Degeneration
  • Intervertebral Disc Displacement
  • Spinal Stenosis
  • Spinal Curvatures
  • Spondylitis
  • Spondylosis

Keywords

  • Intraoperative Neuromonitoring
  • Motor Evoked Potential
03

In context

Intervertebral Disc Degeneration

462 studies on the registry are indexed under Intervertebral Disc Degeneration; 100 are open to participants now.

Browse Intervertebral Disc Degeneration studies →

Lead sponsor

Allina Health System is the lead sponsor of 38 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients must be ≥18 years of age
  • Patients must be undergoing thoracic or lumbar spine surgery where quadriceps MEP recording would be the standard of care
  • Patients should have normal preoperative quadriceps strength
  • Patients are capable of understanding the and have signed the informed consent document prior to any study-specific screening procedures or evaluations being performed

Exclusion criteria

Exclusion Criteria:

  • Patients with ongoing psychiatric concerns would be excluded.
  • Patients who are non-English speakers.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Experimental Arm

    Receive Quadriceps MEPs during procedure

    Other: Quadriceps and Rectus Femoris MEP Recording

Interventions

  • OtherQuadriceps and Rectus Femoris MEP Recording

    Participants will receive additional electrodes placed intramuscularly to facilitate three separate approaches of quadriceps MEP recording

06

What researchers measure

Primary outcomes

  1. Motor Evoked Potentials recorded with an Intramuscular bipolar electrodes in the Rectus Femoris

    MEPs will be evoked throughout the duration of the surgery. MEPs will be recorded in the Rectus Femoris using intramuscular bipolar electrodes.

    Time frame: Duration of surgery

  2. Motor Evoked Potentials recorded with a subcutaneous referential electrodes in the Rectus Femoris

    MEPs will be evoked throughout the duration of the surgery. Electrodes will be placed in the Rectus Femoris to serve as a reference.

    Time frame: Duration of surgery

  3. Motor Evoked Potentials recorded with secondary subcutaneous referential electrodes in the Rectus Femoris

    MEPs will be evoked throughout the duration of the surgery. Electrodes will be placed in the Rectus Femoris to serve as a reference.

    Time frame: Duration of surgery

07

Study locations

1 site
  • Abbott Northwestern Hospital
    Minneapolis, Minnesota 55447, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2022 to primary completion in Jan 2024, 18 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2021
First posted
Oct 28, 2021
StartActual
Jul 1, 2022
Primary completionActual
Jan 1, 2024
CompletionActual
Jan 1, 2024
Last update
Jul 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05098431
Lead sponsor
Allina Health System
Responsible party
Sponsor
First posted
Oct 28, 2021
Start date
Jul 1, 2022
Primary completion
Jan 1, 2024
Completion
Jan 1, 2024
Last update
Jul 12, 2024

Study contacts

Jeffrey A Strommen, MD
principal investigator · Allina Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion